Free Trial
NYSE:MLSS

Milestone Scientific (MLSS) Stock Price, News & Analysis

Milestone Scientific logo
$0.31 +0.02 (+5.86%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$0.30 -0.01 (-2.61%)
As of 11/13/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Milestone Scientific Stock (NYSE:MLSS)

Advanced

Key Stats

Today's Range
$0.29
▼
$0.32
50-Day Range
$0.29
▼
$0.47
52-Week Range
$0.22
▼
$0.58
Volume
146,277 shs
Average Volume
721,141 shs
Market Capitalization
$27.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.00
Consensus Rating
Buy

Company Overview

Milestone Scientific develops and commercializes computer-controlled drug-delivery instruments for dental and medical applications. Its technology is designed to regulate the flow and pressure of injections, with the aim of improving control and reducing discomfort during procedures.

In dentistry, the company offers systems including the STA Single Tooth Anesthesia System and CompuDent, which are used to deliver local anesthetic. Its medical products include the CompuFlo system, designed for applications such as epidural injections and other procedures involving controlled drug delivery.

Milestone Scientific sells its products in the United States and internationally through sales and distribution channels. The company has focused on expanding the use of its injection technology beyond dentistry into broader medical and pain-management settings.

AI Generated. May Contain Errors.

Milestone Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
36th Percentile Overall Score

MLSS MarketRank™: 
1.805355033465 of 5 stars

Milestone Scientific scored higher than 36% of companies evaluated by MarketBeat, and ranked 726th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Milestone Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.

  • Upside Potential

    Milestone Scientific has a consensus price target of $1.00, representing about 225.7% upside from its current price of $0.31.

  • Amount of Analyst Coverage

    Milestone Scientific has only been the subject of 1 research reports in the past 90 days.

  • Read more about Milestone Scientific's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Milestone Scientific is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Milestone Scientific is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Milestone Scientific has a P/B Ratio of 2.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for MLSS.
  • Dividend Yield

    Milestone Scientific does not currently pay a dividend.

  • Dividend Growth

    Milestone Scientific does not have a long track record of dividend growth.

  • News Sentiment

    Milestone Scientific has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Milestone Scientific this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Milestone Scientific insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    9.22% of the stock of Milestone Scientific is held by insiders.

  • Percentage Held by Institutions

    5.79% of the stock of Milestone Scientific is held by institutions.

  • Read more about Milestone Scientific's insider trading history.
Receive MLSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MLSS Stock News Headlines

Milestone Scientific (MLSS) Q3 2026 Earnings Call Transcript
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel
Milestone Scientific Reports Financial Results for Third Quarter 2026
See More Headlines

MLSS Stock Analysis - Frequently Asked Questions

Milestone Scientific's stock was trading at $0.2730 on January 1st, 2026. Since then, MLSS shares have increased by 12.5% and is now trading at $0.3070.

Milestone Scientific Inc. (NYSE:MLSS) posted its quarterly earnings results on Thursday, August, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The firm had revenue of $1.85 million for the quarter. Milestone Scientific had a negative net margin of 52.01% and a negative trailing twelve-month return on equity of 60.26%.

Milestone Scientific's top institutional investors include State Street Corp (0.29%), NFSG Corp (0.24%) and Empowered Funds LLC (0.11%). Insiders that own company stock include SRL Bp4, Leonard Osser and Michael Mcgeehan.
View institutional ownership trends
.

Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Milestone Scientific investors own include BIOLASE (BIOL), ChronoScale Corporation Common Stock (CHRN), Clearside Biomedical (CLSD), Citius Pharmaceuticals (CTXR), CohBar (CWBR), Cyclacel Pharmaceuticals (CYCC) and Fortress Biotech (FBIO).

Company Calendar

Today
11/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSE:MLSS
CIK
855683
Employees
15
Year Founded
1989

Price Target and Rating

High Price Target
$1.00
Low Price Target
$1.00
Potential Upside/Downside
+225.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.93 million
Net Margins
-52.01%
Pretax Margin
-52.21%
Return on Equity
-60.26%
Return on Assets
-40.23%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.85
Quick Ratio
1.86

Sales & Book Value

Annual Sales
$9.42 million
Price / Sales
2.95
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.11 per share
Price / Book
2.79

Miscellaneous

Outstanding Shares
90,644,000
Free Float
58,614,000
Market Cap
$27.83 million
Optionable
Optionable
Beta
1.14

Social Links

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NYSE:MLSS) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners